Recent advances in the diagnosis and treatment of influenza pneumonia

Current Infectious Disease Reports

Volumn 14, Issue 3, 2012, Pages 275-283

  Marzoratti, Lucia ^a   Iannella, Hernán A ^b   Gómez, Victoria Fernández ^a   Figueroa, Sandra B ^a  

^a CEMIT Centro Médico Investigadores Tucumán   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Avian influenza; Diagnosis; H1N1; Influenza pneumonia; Pandemic; Prevention; Swine influenza; Treatment

Indexed keywords

AMANTADINE; INFLUENZA VACCINE; LANINAMIVIR OCTANOATE; OSELTAMIVIR; PERAMIVIR; PLACEBO; RIMANTADINE; SIALIDASE INHIBITOR; ZANAMIVIR;

2009 H1N1 INFLUENZA; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDICATION; DRUG METABOLISM; DRUG SAFETY; FLU LIKE SYNDROME; HUMAN; IMMUNOFLUORESCENCE; INFECTION PREVENTION; INFLUENZA; INFLUENZA A; INFLUENZA A (H5N1); INFLUENZA B; INFLUENZA VACCINATION; LOWER RESPIRATORY TRACT INFECTION; NAUSEA AND VOMITING; OUTCOME ASSESSMENT; PNEUMONIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEASONAL INFLUENZA; SENSITIVITY AND SPECIFICITY; SEROLOGY; THORAX RADIOGRAPHY; THROAT CULTURE; TREATMENT INDICATION; VIRUS CULTURE; VIRUS RESISTANCE;

EID: 84865616069     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-012-0257-5     Document Type: Article

References (78)

1. MontoAS, Gravenstein S, Elliott M, et al. Clinical predicting influenza infection. Arch Intern Med. 2000;160:243-7.
2. Harper SA, Bradley JS, Englund JA, et al.: Seasonal Influenza in Adults and Children-Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:1003-1032. Evidence-based guidelines for the diagnosis and treatment of patients with influenza, published by the IDSA. 2. 9.
3. Guidance for clinicians on the use of rapid influenza diagnostic tests for the 2010-2011 influenza season. Available at http://www.cdc.gov/flu/pdf/ professionals/diagnosis/clinician-guidance-ridt.pdf. Accessed October 2011. Most recent CDC guidelines for the use of rapid influenza diagnostic tests.
4. MontoAS, Gravenstein S, Elliott M, et al. Clinical signs and symptoms predicting influenza infection. Arch Intern Med. 2000;160:3243-7.
5. Boivin G, Hardy I, Tellier G, et al. Predicting influenza infections during epidemics with use of a clinical case definition. Clin Infect Dis. 2000;31:1166-9. (Pubitemid 32295445)
6. Call SA, Vollenweider MA, Hornung CA, et al. Does this patient have influenza? JAMA. 2005;293:987-97. (Pubitemid 40271131)
7. 1) virus in humans. N Engl J Med. 2009;360:2605-15.
8. 1) virus infection. N Engl J Med. 2010;362:1708-19.
9. 1), and 2007-2008 (H3N2) infections. JAMA. 2010;304:1091-8.
10. 1) virus infection in hospitalized adults: How do they differ from those in seasonal influenza? J Infect Dis. 2011;203:1739-47.
11. Kim EA, Lee KS, Primack SL, et al. Viral pneumonias in adults: radiologic and pathologic findings. Radiographics. 2002;22:S137-49. (Pubitemid 41569703)
12. Peltola VT, Murti KG, McCullers JA. Influenza virus neuraminidase contributes to secondary bacterial pneumonia. J Infect Dis. 2005;192:249-57. (Pubitemid 40993394)
13. King QO, Lei B, Harmsen AG. Pneumococcal surface protein A contributes to secondary Streptococcus pneumoniae infection after influenza virus infection. J Infect Dis. 2009;200:537-45.
14. 1 influenza-Associated pneumonia. N Engl J Med. 2009;361:e112.
15. 1) 2009: risk factors, clinical features, and outcomes. Medicine (Baltimore). 2011;90:328-36.
16. Kallen AJ, Brunkard J, Moore Z, et al. Staphylococcus aureus community-Acquired pneumonia during the 2006 to 2007 influenza season. Ann Emerg Med. 2009;53:358-65.
17. Hageman JC, Uyeki TM, Francis JS, et al. Severe communityacquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis. 2006;12:894-9. (Pubitemid 43848409)
18. Centers for Disease Control and Prevention (CDC): Severe methicillin-resistant Staphylococcus aureus community-Acquired pneumonia associated with influenza-Louisiana and Georgia, December 2006-January 2007. MMWR Morb Mortal Wkly Rep 2007, 56:325-329.
19. 1) Infection: Impact of Community-Associated Methicillin Resistant Staphylococcus aureus (MRSA) in Queensland, Australia. Intern Med J 2011, In press.
20. Randolph AG, Vaughn F, Sullivan R, et al. Critically Ill Children During the 2009-2010 Influenza Pandemic in the United States. Pediatrics. 2011; e1450-e1458
21. 1 influenza. N Engl J Med 2009, 361:674-679. An observational study in which the authors assessed the features on the 2009 swine influenza pandemic and found an increase in the rate of severe pneumonia and a shift in the age distribution of patients, compared to seasonal influenza cases.
22. 1 influenza outbreak that supported the fact that this strain causes severe illness, ARDS and death in previously healthy persons who are young to middleaged.
23. 1). They found that both CURB-65 and PSI were not accurate in predicting ICU admission.
24. 1) Virus in Admitted and Critically Ill Patients. J Intensive Care Med 2011, In press.
25. Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus, Abdel-Ghafar AN, Chotpitayasunondh T, et al.: Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 2008, 358:261-273.
26. Booth S, Baleriola C, Rawlinson WD. Comparison of two rapid influenza A/B test kits with reference methods showing high specificity and sensitivity for influenza A infection. J Med Virol. 2006;78:619-22.
27. Hurt AC, Alexander R, Hibbert J, et al. Performance of six influenza rapid tests in detecting human influenza in clinical specimens. J Clin Virol. 2007;39:132-5. (Pubitemid 46777422)
28. Smit M, Beynon KA, Murdoch DR, et al. Comparison of the NOW Influenza A&B,NOWFlu A,NOWFlu B, and Directigen Flu A+B assays, and immunofluorescence with viral culture for the detection of influenza A and B viruses. Diagn Microbiol Infect Dis. 2007;57:67-70. (Pubitemid 44908833)
29. Rahman M, Vandermause MF, Kieke BA, et al. Performance of Binax NOW Flu A and B and direct fluorescent assay in comparison with a composite of viral culture or reverse transcription polymerase chain reaction for detection of influenza infection during the 2006 to 2007 season. Diagn Microbiol Infect Dis. 2008;62:162-6.
30. 1) Virus -United States, 2009. MMWR Morb Mortal Wkly Rep 2009, 58:826-829.
31. 1. Clin Infect Dis. 2009;49:1090-3.
32. 1) 2009 virus. Emerg Infect Dis. 2009;15:1662-4.
33. Pongthanapisith V, Sukasem C, Premchaiporn K, et al. Clinical performance of three rapid diagnostic tests for influenza virus in nasopharyngeal specimens to detect novel swine-origin influenza viruses. Infection. 2011;39:105-11.
34. Landry ML, Cohen S, Ferguson D. Real-Time PCR compared to Binax NOW and cytospin-immunofluorescence for detection of influenza in hospitalized patients. J Clin Virol. 2008;43:148-51.
35. Taubenberger JK, Layne SP. Diagnosis of influenza virus: Coming to grips with the molecular era. Mol Diagn. 2001;6:291-305. (Pubitemid 34042377)
36. Ellis JS, Zambon MC. Molecular diagnosis of influenza. Rev Med Virol. 2002;12:375-89. (Pubitemid 35334423)
37. 1 influenza A pandemic.
38. 1 2009 virus. J Clin Microbiol. 2011;49:1434-40.
39. 1) 2009 virus. J Med Virol. 2010;82:675-83.
40. 1 2009 virus by real-Time reverse transcriptase PCR. J Clin Microbiol. 2010;48:3492-5.
41. Centers for Disease Control and Prevention (CDC): Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011.
42. MMWR Morb Mortal Wkly Rep 2011, 60:1128-1132. Latest recommendations for influenza vaccination from the CDC.
43. Fiore AE, Fry A, Shay D, et al.: Antiviral agents for the treatment and chemoprophylaxis of influenza -recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011,60:1-24. ACIP recommendations on the use of antiviral medications for the treatment and prevention of influenza.
44. Toovey S, Rayner C, Prinssen E, et al. Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: A comprehensive review. Drug Saf. 2008;31:1097-114.
45. Tanabe T, Hara K, Nakajima M, et al. Oseltamivir treatment for children showing abnormal behavior during influenza virus infection. Brain Dev. 2010;32:440-4.
46. Williamson JC, Pegram PS. Neuraminidase inhibitors in patients with underlying airways disease. Am J Respir Med. 2002;1:85-90. (Pubitemid 37038926)
47. Keyser LA, Karl M, Nafziger AN, et al. Comparison of central nervous system adverse effects of amantadine and rimantadine used as sequential prophylaxis of influenza A in elderly nursing home patients. Arch Intern Med. 2000;160:1485-8. (Pubitemid 30327452)
48. Cooper NJ, Sutton AJ, Abrams KR, et al. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: Systematic review and meta-Analyses of randomised controlled trials. BMJ. 2003;326:1235.
49. Jefferson T, Demicheli V, Rivetti D, et al. Antivirals for influenza in healthy adults: Systematic review. Lancet. 2006;367:303-13. (Pubitemid 43151463)
50. Jefferson T, Jones M, Doshi P, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: Systematic review and meta-Analysis. BMJ. 2009;339:b5106.
51. Burch J, Corbett M, Stock C, et al. Prescription of anti-influenza drugs for healthy adults: A systematic review and meta-Analysis. Lancet Infect Dis. 2009;9:537-45.
52. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group. Lancet 1998, 352:1877-1881.
53. Kaiser L, Wat C, Mills T, et al. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med. 2003;163:1667-72. (Pubitemid 36898954)
54. Hernán MA, Lipsitch M. Oseltamivir and risk of lower respiratory tract complications in patients with flu symptoms: A meta-Analysis of eleven randomized clinical trials. Clin Infect Dis. 2011;53:277-9.
55. Lee N, Chan PK, Choi KW, et al. Factors associated with early hospital discharge of adult influenza patients. Antivir Ther. 2007;12:501-8. (Pubitemid 47041148)
56. McGeer A, Green KA, Plevneshi A, et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis. 2007;45:1568-75. (Pubitemid 351411840)
57. 1). N Engl J Med. 2009;361:e110.
58. 1 influenza in the United States, April-June 2009. N Engl J Med. 2009;361:1935-44.
59. Rodríguez A, Díaz E, Martín-Loeches I, et al. Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A. J Antimicrob Chemother. 2011;66:1140-9.
60. 1: Opportunistic retrospective study of medical charts in China. BMJ. 2010;341:c4779.
61. 1 and seasonal influenza among hematopoietic cell transplant recipients. Blood. 2011;117:5050-6.
62. 1 influenza. N Engl J Med. 2010;362:88-9.
63. 1 pneumonitis treated with intravenous zanamivir. Lancet. 2009;374:1036.
64. 1) 2009 influenza virus. Clin Infect Dis. 2010;50:1249-51.
65. 1) virus. Clin Infect Dis. 2010;50:1493-6.
66. Kohno S, Kida H, Mizuguchi M, et al. Intravenous peramivir for treatment of influenza A and B virus infection in high-risk patients. Antimicrob Agents Chemother. 2011;55:2803-12.
67. Kohno S, Kida H, Mizuguchi M, et al. Efficacy and safety of intravenous peramivir for treatment of seasonal influenza virus infection. Antimicrob Agents Chemother. 2010;54:4568-74.
68. Watanabe A, Chang SC, Kim MJ, et al. Long-Acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: A double-blind, randomized, noninferiority clinical trial. Clin Infect Dis. 2010;51:1167-75.
69. Kandun IN, Tresnaningsih E, Purba WH, et al. Factors associated with case fatality of human H5N1 virus infections in Indonesia: A case series. Lancet. 2008;372:744-9.
70. Liem NT, Tung CV, Hien ND, et al. Clinical features of human influenza A (H5N1) infection in Vietnam: 2004-2006. Clin Infect Dis. 2009;48:1639-46.
71. WHO. Clinical management of human infection with avian influenza A (H5N1) virus (15 August 2007). Available at http://www.who.int/influ enza/resources/documents/clinical-management-h5n1-15-08-2007/en/index.html. Accessed: November 2011. 70. 9.
72. Centers for Disease Control and Prevention. 2011-2012 influenza antiviral medications: Summary for clinicians. Available at http://www.cdc.gov/flu/ professionals/antivirals/summary-clinicians.htm. Accessed November 2011. CDC guidelines for the use of antiviral medications for the treatment and prevention of influenza.
73. 1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation. Euro Surveill 2011, 16.
74. Hayden FG, de Jong MD. Emerging influenza antiviral resistance threats. J Infect Dis. 2011;203:6-10.
75. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-Acquired pneumonia in adults. Clin Infect Dis. 2007;44:S27-72. (Pubitemid 46290553)
76. 1 influenza A pandemic, lower respiratory tract compromise was rapidly progressive, oftenly leading to respiratory failure and requiring salvage therapies.
77. 1). JAMA. 2011;306:1659-68.
78. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296-327.